Sisram Med 01696 Prospectus Information

Company Overview

Stock Name	Sisram Med
Stock Code	01696
Company Full Name	To be extracted
Industry	醫療保健
Principal Activities	主要從事設計、開發、制造及銷售醫療美容器械。
Listing Date	2017-09-19
Listing Rules Era	Old Rules
Listing Rules Chapter	To be extracted
Weighted Voting Rights (WVR)	No
Registered Address (Mainland China)	3079895 以色列凱撒利亞工業園區哈哈拉什街18號Ofek 15號樓
Business Address (Hong Kong)	To be extracted
Place of Incorporation	To be extracted
Listing Method	To be extracted
Listing Board	Main Board
Website	http://www.sisram-medical.com
Share Registrar	香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact	(852)2862 8628
A-Share/US Dual Listing	No data

Offering Information

Offering Mechanism	To be extracted
Offer Price	HK$ 8.88 / shares
Offer Price Range	To be extracted
Lot Size	To be extracted
Entry Threshold	To be extracted
Par Value	To be extracted
Offer Period	To be extracted
Global Offering Shares	To be extracted
HK Public Offer Shares (Initial)	To be extracted
Public Offer Lots (Initial)	To be extracted
International Placing Shares (Initial)	To be extracted
Offer Ratio	To be extracted
Total Shares Post-IPO	To be extracted
Greenshoe (Over-allotment Option)	To be confirmed
Stabilizing Manager (Greenshoe)	—
Cornerstone Share	5.8%
Clawback Tiers	To be extracted
Reallocation Option	To be confirmed
Total Global Offering Size	HK$ 293,040,000

Stock Connect Inclusion

HK Market Cap	---

26Q2 Regular Review
Inclusion Pathway	None
Est. Threshold	---
Analysis Result	无法确定入通路径

Valuation & Financials

Market Cap (at Offer Price)	To be extracted
Pre-IPO Valuation (Last Round)	Not disclosed
P/E Ratio	Not disclosed
Profit/Loss Status	To be extracted
Period-End Cash Balance	To be extracted
Listing Expenses	To be extracted
Listing Expenses / Funds Raised	To be extracted
Total Pre-IPO Investment	To be extracted

First Day Performance

First Day Close	HK$ 8.12
First Day Open	HK$ 8.79
First Day Change	-8.56%
First Day Volume	38948500.0
First Day Turnover	329538000.0

Use of Proceeds

Use of Proceeds	1、約18.6%，或約128.4百萬港元，預期用于擴展我們的銷售渠道及分銷網絡以及加強我們的營銷力度； 2、約18.6%，或約128.4百萬港元，用于資本開支； 3、約14.0%，或約96.3百萬港元，預期用于研究及開發活動； 4、約9.3%，或約64.2百萬港元，預期將用于償還關聯方復星實業（香港）有限公司的收購貸款； 5、約29.5%，或約202.5百萬港元，預期將用于策略性收購、設立戰略合作關系，以及其他業務發展； 6、約10.0%，或約68.9百萬港元，預期用作營運資金及一般公司用途。

1、約18.6%，或約128.4百萬港元，預期用于擴展我們的銷售渠道及分銷網絡以及加強我們的營銷力度； 2、約18.6%，或約128.4百萬港元，用于資本開支； 3、約14.0%，或約96.3百萬港元，預期用于研究及開發活動； 4、約9.3%，或約64.2百萬港元，預期將用于償還關聯方復星實業（香港）有限公司的收購貸款； 5、約29.5%，或約202.5百萬港元，預期將用于策略性收購、設立戰略合作關系，以及其他業務發展； 6、約10.0%，或約68.9百萬港元，預期用作營運資金及一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)

China International Capital Corporation Hong Kong Securities Limited CE AEN894 Jefferies Hong Kong Limited CE ATS546

Overall Coordinators (3)

China International Capital Corporation Hong Kong Securities Limited CE AEN894 Jefferies Hong Kong Limited CE ATS546 Fosun International Securities Limited CE AAF432

Joint Bookrunners (5)

China International Capital Corporation Hong Kong Securities Limited CE AEN894 Jefferies Hong Kong Limited CE ATS546 Fosun International Securities Limited CE AAF432 HAITONG INTERNATIONAL SECURITIES COMPANY LIMITED CE AAF806 Huatai Financial Holdings (Hong Kong) Limited CE AOK809

Joint Lead Managers (5)

Cornerstone Investors

#	Investor Name	Investment Amount	Shares Subscribed	% of Offer Shares	% of Total Shares	Lock-up Period	Est. Unlock Date
1	纽顿医学美容集团有限公司	29,637,888 HKD	—	0.76%	—	6 months	2018-03-19
2	上海自贸试验区一期股权投资基金合伙企业(有限合伙)	116,999,328 HKD	—	2.99%	—	6 months	2018-03-19
3	升泰有限公司	77,998,368 HKD	—	2.00%	—	6 months	2018-03-19

Directors & Management

Chairman	Lior Moshe DAYAN
Company Secretary	方前厲

No director data available.

Major Shareholders

Major Shareholders & Holdings	上海復星醫藥(集團)股份有限公司(71.16%)

Sisram Med 01696Prospectus Information